Skip to main content
. 2022 May 23;12(10):3783–3821. doi: 10.1016/j.apsb.2022.05.020

Figure 14.

Figure 14

The action mechanism of SGLT1/2 inhibitors. (A) The glucose reabsorption mechanism of SGLT1/2 in renal tubule. (B) The SGLT2 inhibitory natural glycoside phlorizin (104), an active derivative T-1095 (105), and its metabolite T-1095A (106).